CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 1, 2024 · earnings

SYRE earnings: a positive outcome, +9.0%

On March 1, 2024, Spyre Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +9.0% in the window around the event.

The move

$27.44
1d before
$29.90
Event day
$29.90
1d after
$40.26
5d after

Pre-catalyst setup

-3.9%
30-day run-up
7660%
30-day volatility
2.6×
volume spike